Related Experiment Video
Updated: Aug 4, 2026

Oral Biofilm Formation on Different Materials for Dental Implants
Published on: June 24, 2018
Evaluation of Anti-Biofilm Property of Zirconium Oxide Nanoparticles on Streptococcus mutans and Enterococcus
Anu Priya Guruswamy Pandian1, Anil Kumar Ramachandran2, Priyanka Kodaganallur Pitchumani3
1Endodontics, Private Practice, Los Angeles, USA.
Abstract:
Introduction The prevalence of dental caries and endodontic infections caused by bacteria such as Streptococcus mutans and Enterococcus faecalis poses a significant challenge in root canal treatment. These pathogens exhibit significant resistance to antimicrobial treatments due to their ability to form biofilms, complex microbial communities encased in a self-produced extracellular polymeric substance (EPS). Despite advancements in treatment strategies, the failure rate remains high due to the difficulty in completely eradicating microbial populations within the complex root canal system. The increasing prevalence of antibiotic resistance has driven the need for novel antimicrobial agents and strategies to target biofilms. In this study, we evaluated the potential of zirconium oxide nanoparticles (ZrO2 NPs) in eradicating biofilms formed by S. mutans and E. faecalis, two key pathogens involved in these infections. Materials and methods ZrO2 NPs were characterized and evaluated for their antimicrobial properties against E. faecalis and S. mutans biofilms. The nanoparticles were characterized using scanning electron microscopy and energy-dispersive X-ray spectroscopy. Biofilm quantification was performed using a crystal violet staining assay. The minimum biofilm eradication concentrations of ZrO2 NPs against the bacterial strains were determined. Results ZrO2 NPs used in our study were found to have zirconium predominantly with no impurities. Also, the average particle size was less than 30 nm with a spherical shape arranged in clusters. These characterizations were performed considering the vital role of these properties in obtaining the desired antibacterial/anti-biofilm properties of nanoparticles. ZrO2 NPs were capable of eradicating the biofilm formed by both S. mutans and E. faecalis at concentrations greater than 22.8 μg/mL. The results suggest that ZrO2 NPs could be used as a novel approach for combating biofilm-related infections. Conclusion Our findings suggest that ZrO2 NPs have the potential to be a promising antibiofilm agent in root canal treatment, offering a new approach to combat these persistent infections. Further research is warranted to explore the full potential of nanomaterials in improving treatment outcomes in endodontic infections.

